Selected article for: "control sera and positive control sera"

Author: Rafael R. de Assis; Aarti Jain; Rie Nakajima; Algis Jasinskas; Jiin Felgner; Joshua M. Obiero; Oluwasanmi Adenaiye; Sheldon Tai; Filbert Hong; Philip Norris; Mars Stone; Graham Simmons; Anil Bagri; Martin Schreiber; Andreas Buser; Andreas Holbro; Manuel Battegay; Donald K. Milton; Huw Davies; Laurence M. Corash; Michael P. Busch; Philip L. Felgner; Saahir Khan
Title: Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a Coronavirus Antigen Microarray
  • Document date: 2020_4_17
  • ID: ax9btc74_16
    Snippet: A coronavirus antigen microarray containing a panel of antigens from SARS-CoV-2 in addition to other human coronaviruses was able to reliably distinguish convalescent plasma of PCR-positive COVID-19 cases from negative control sera collected prior to the pandemic by detecting both strain-specific and cross-reactive antibodies. Further studies are needed to apply this methodology to large-scale serologic surveillance studies and to correlate speci.....
    Document: A coronavirus antigen microarray containing a panel of antigens from SARS-CoV-2 in addition to other human coronaviruses was able to reliably distinguish convalescent plasma of PCR-positive COVID-19 cases from negative control sera collected prior to the pandemic by detecting both strain-specific and cross-reactive antibodies. Further studies are needed to apply this methodology to large-scale serologic surveillance studies and to correlate specific antibody responses with clinical outcomes.

    Search related documents:
    Co phrase search for related documents
    • antibody response and clinical outcome antibody response: 1, 2, 3, 4, 5, 6
    • antibody response and cross reactive antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • antibody response and large scale: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody response and PCR positive case: 1
    • antibody response and reliably distinguish: 1
    • antibody response and serologic surveillance: 1
    • antibody response and specific clinical outcome antibody response: 1, 2
    • antibody response and strain specific cross reactive antibody: 1, 2
    • antigen panel and large scale: 1, 2
    • antigen panel contain and large scale: 1, 2
    • clinical outcome and large scale: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical outcome and PCR positive case: 1
    • clinical outcome and specific clinical outcome antibody response: 1, 2
    • clinical outcome antibody response and specific clinical outcome antibody response: 1, 2
    • cross reactive antibody and large scale: 1
    • cross reactive antibody and reliably distinguish: 1
    • large scale and reliably distinguish: 1
    • large scale and serologic surveillance: 1, 2
    • PCR positive case and serologic surveillance: 1, 2